Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease

ClinicalTrials.gov ID: NCT03036150

Public ClinicalTrials.gov record NCT03036150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 5:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease.

Study identification

NCT ID
NCT03036150
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
4,304 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2, 2017 (Actual)
Primary completion
Jun 12, 2020 (Actual)
Completion
Jun 12, 2020 (Actual)
Last update posted
Jul 7, 2021

2017 – 2020

United States locations

U.S. sites
55
U.S. states
22
U.S. cities
49
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 —
Research Site Hawaiian Gardens California 90716 —
Research Site Lomita California 90717 —
Research Site Los Angeles California 90022 —
Research Site Palo Alto California 94304 —
Research Site San Dimas California 91773 —
Research Site San Ramon California 94582 —
Research Site Vista California 92083 —
Research Site Aurora Colorado 80045 —
Research Site Denver Colorado 80246 —
Research Site Boynton Beach Florida 33435 —
Research Site Boynton Beach Florida 33472 —
Research Site Jacksonville Florida 32224 —
Research Site Miami Florida 33015 —
Research Site Miami Florida 33144 —
Research Site Miami Florida 33165 —
Research Site Miami Lakes Florida 33014 —
Research Site Naples Florida 34102 —
Research Site New Port Richey Florida 34652 —
Research Site Atlanta Georgia 30342-1797 —
Research Site Augusta Georgia 30904 —
Research Site Chicago Illinois 60643 —
Research Site Iowa City Iowa 52242 —
Research Site Topeka Kansas 66606 —
Research Site Wichita Kansas 67214 —
Research Site Metairie Louisiana 70006 —
Research Site Boston Massachusetts 02111 —
Research Site Detroit Michigan 48202 —
Research Site Flint Michigan 48504 —
Research Site Duluth Minnesota 55805 —
Research Site Omaha Nebraska 68105 —
Research Site Albany New York 12208 —
Research Site Asheville North Carolina 28801 —
Research Site Charlotte North Carolina 28207 —
Research Site Hickory North Carolina 28601 —
Research Site New Bern North Carolina 28562 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Cincinnati Ohio 45219 —
Research Site Maumee Ohio 43537 —
Research Site Jersey Shore Pennsylvania 17740 —
Research Site Philadelphia Pennsylvania 19104 —
Research Site Greer South Carolina 29651 —
Research Site Kingsport Tennessee 37660 —
Research Site Nashville Tennessee 37232 —
Research Site El Paso Texas 79935 —
Research Site Fort Worth Texas 76116 —
Research Site Fort Worth Texas 76117 —
Research Site Fort Worth Texas 76164 —
Research Site Houston Texas 77004 —
Research Site Houston Texas 77030 —
Research Site Odessa Texas 79761 —
Research Site Burke Virginia 22015 —
Research Site Manassas Virginia 20110 —
Research Site Newport News Virginia 23606 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 335 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03036150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03036150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →